Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
- B6689 Butabindide oxalateSummary: CCK-inactivating serine protease (tripeptidyl peptidase II) inhibitor
- B7719 TC-E 5006Summary: γ-secretase modulator
- B5153 Y-29794 oxalateSummary: Inhibitor of prolyl endopeptidase
- B5415 PF 429242Summary: inhibitor of sterol regulatory element-binding protein (SREBP) site 1 protease
- B5657 MKT 077Summary: mortalin-2 (mot-2) inhibitor
- A8200 DAPT (GSI-IX)6 CitationSummary: γ-secretase inhibitor
- A4005 RO49290971 CitationSummary: γ secretase inhibitor
- A4006 MK-07521 CitationSummary: γ-secretase inhibitor
- A2573 AEBSF.HCl1 CitationTarget: Serine ProteasesSummary: serine protease inhibitor
- A2574 Aprotinin1 CitationTarget: Trypsin|Chymotrypsin|Kallikrein|TrypsinogenSummary: serine protease inhibitor